Clinical trial
Using Live Vaccines to Induce Beneficial Innate Immune Training and Reduce Systemic Inflammation in COPD Patients.
NCT06257212 is registered in ClinicalTrials.gov with Josefin Eklöf as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Using Live Vaccines to Induce Beneficial Innate Immune Training and Reduce Systemic Inflammation in COPD Patients.
- Lead sponsor
- Josefin Eklöf
- Phase
- Phase 4
- Overall status
- Completed
- Start date
- February 28, 2024
- Completion date
- August 25, 2025
- Enrollment
- 60 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
copd, trained innate immunity